Date:7/29/2010

,'ExternalLink');" target='_blank' href="http://www.pfscm.org/">www.pfscm.org) was established by JSI Research & Training Institute, Inc., and Management Sciences for Health. The partnership's 13 team member organizations include non-profit organizations, commercial private sector corporations and academic institutions.

The European Supply Chain and Logistics Summit (SCL Europe 2010) took place 7th - 9th June 2010 at the Clarion Congress Hotel, Prague, Czech Republic, with attendance by more than 250 directors and heads of supply chain and logistics.

http://www.supplychainawards.com/index.asp

Public Information: 202-712-4810

'/>"/>

SOURCE U.S. Agency for International Development Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. UPDATE: FDA Issues 22 Warning Letters to Web site Operators
2. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
3. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
4. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
5. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
7. UPDATE: Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure
8. New Edition of Guidelines for Involving Communities in HIV Prevention Research Released at International AIDS Conference
9. SRI International and Stanford University School of Medicines MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices
10. Encorium Group, Inc. Acquires Progenitor International Research, a Vaccine Focused Emerging Market CRO
11. Noscira Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimers Disease at International Conference on Alzheimers Disease (ICAD)